Recent Quotes (30 days)

You have no recent quotes
chg | %

Natco Pharma Ltd.  

(Public, BOM:524816)   Watch this stock  
Find more results for 524816
999.00
+36.65 (3.81%)
Real-time:   9:56AM GMT+5:30
BOM real-time data - Disclaimer
Currency in INR
Range 974.75 - 1,012.50
52 week 555.50 - 1,080.00
Open 975.05
Vol. 11,133.00
Mkt cap 173.55B
P/E 31.50
Div/yield 1.25/0.73
EPS 31.72
Shares 174.31M
Beta     -
Inst. own     -

Key stats and ratios

Q3 (Sep '17) 2017
Net profit margin 19.78% 23.48%
Operating margin 24.82% 30.47%
EBITD margin - 33.22%
Return on average assets - 23.43%
Return on average equity - 33.01%
Employees 4,411 -
CDP Score - -

Address

Natco House, Road No 2, Banjara Hills
HYDERABAD, 500034
India
+91-40-23547532 (Phone)
+91-40-23545298 (Fax)

Website links

Description

Natco Pharma Limited is a pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The Company's segments include active pharmaceuticals ingredient, finished dosage formulations, job works, pharmacy and others. The Company's product categories include Domestic Formulations, International Formulations, API's and Blockbusters. The Company's products include Alphalan, Bandrone, Bendit, Clokeran, Lenalid, Thioplan, Anastronat, Capnat, Fulvenat, Kabanat, Natdox-LP, Rapact, Temonat, X-Trant, Glatimer, Hepcinat, Natdac, Natzold, Tigi, Alprazolam, Chloroquine Phosphate, Lansoprazole, Letrozole, Granisetron, Rizatriptan IR, Imatinib, Salmeterol Xinafoate, Sertraline Form I, Ibandronate Sodium Monohydrate, Pantoprazole Sodium Sesquihydrate, Ondansetron Hydrochloride (Injectable Grade), Daclatasvir and Glatiramer Acetate. The Company manufactures over 20 products under contract.

Officers and directors

V. C. Nannapaneni Executive Chairman of the board, Managing Director
Age: 68
Rajeev Nannapaneni Executive Vice Chairman of the Board, Chief Executive Officer
Age: 37
S. V. V. N. Appa Rao Chief Financial Officer, Vice President - Finance and Accounts
Linga Rao President - Technical Affairs, Director
P. S. R. K. Prasad Executive Vice President - Corporate Engineering Services, Additional Wholetime Director
M. Adinarayana Compliance Officer, Company Secretary, Vice President - Legal & Corporate Affairs
Vivek Chhachhi Additional Director - Nominee of CX Securities Ltd.
M. U. R. Naidu Additional Director
Leela Digumarti Independent Director
D. G. Prasad Independent Additional Director